Patent Assignment
Reel/Frame 052858/0844
Assignment of Assignor's Interest
Recorded: 2020-06-05
Pages: 9
Assignors
KRUPNICK, ALEXANDER SASHA
Executed: 2020-06-05
LAZEAR, ERIC REED
Executed: 2020-06-04
HEIN, SARAH
Executed: 2020-06-04
WATKINS, DANIEL MARVIN
Executed: 2020-06-04
Assignee
COURIER THERAPEUTICS, INC.
3737 BUFFALO SPEEDWAY, SUITE 1750, HOUSTON, TEXAS, 77098
Covered Properties
(2)
BISPECIFIC FUSION PROTEIN USING ORTHOPOXVIRUS MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) CLASS l-LIKE PROTEIN (OMCP) AND TUMOR-SPECIFIC BINDING PARTNER
PCT:
PCT/US2020/018680 ↗
Bispecific Fusion Protein Using Orthopoxvirus Major Histocompatibility Complex (Mhc) Class I-Like Protein (Omcp) and Tumor-Specific Ligands
Application:
62/807,190 →
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Jul 6, 2023
From: VALO HEALTH, LLC; VALO HEALTH, INC.
To: FIRST-CITIZENS BANK & TRUST COMPANY, AS AGENT
Reel/Frame 064207/0957 →
Release of Security Interest
May 13, 2024
From: SILICON VALLEY BANK, A DIVISION OF FIRST-CITIZENS BANK & TRUST COMPANY
To: VALO HEALTH, INC.; VALO HEALTH, LLC
Reel/Frame 067394/0291 →
Assignment of Assignor's Interest
Jun 19, 2024
From: COURIER THERAPEUTICS, INC.
To: CS24 BIOLOGICS, INC.
Reel/Frame 067768/0603 →
Change of Name
Jun 28, 2024
From: CS24 BIOLOGICS, INC.
To: RECOURSE BIOLOGICS, INC.
Reel/Frame 067966/0206 →